Evidence map›Paper›PMID 30038217›Full record

ArticleNature medicine2018

Cytotoxic CD8

Caroline Junqueira, Camila R R Barbosa, Pedro A C Costa, Andréa Teixeira-Carvalho, Guilherme Castro, Sumit Sen Santara, Rafael P Barbosa, Farokh Dotiwala, Dhelio B Pereira, Lis R Antonelli and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Immunoregulation role of the erythroid cells.Frontiers in immunology · 2024
    Review
  18. Article
  19. Immunological characteristics of CD103Parasitology research · 2023
    Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Caroline JunqueiraInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil. carolinejunqueira@minas.fiocruz.br.
Camila R R BarbosaInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Pedro A C CostaInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Andréa Teixeira-CarvalhoInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Guilherme CastroInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Sumit Sen SantaraProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Rafael P BarbosaProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Farokh DotiwalaProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Dhelio B PereiraCentro de Pesquisas em Medicina Tropical, Porto Velho, Brazil.ORCID http://orcid.org/0000-0002-7761-5498
Lis R AntonelliInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Judy LiebermanProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA. judy.lieberman@childrens.harvard.edu.
Ricardo T GazzinelliPlataforma de Medicina Translacional, Fundação Oswaldo Cruz, Ribeirão Preto, Brazil. ricardo.gazzinelli@umassmed.edu.
Boston Children's Hospital · USFundação Oswaldo Cruz · BRFaculdade de Medicina do ABC · BRUniversidade Federal de Minas Gerais · BR

Funding

Sugar-feeding behavior of the malaria vector Nyssorhynchus darlingi and development of effective attractive toxic sugar baits (ATSB) to increase intervention success in PeruU19AI089681 · NIAID · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2010 to 2023
$20.1M
Innate Immune Activation in MalariaR01AI079293 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., GOLENBOCK, DOUGLAS T · 2009 to 2024
$10.9M
Granzyme and Granulysin Mediated Death of Trypanosoma cruziR01AI116577 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI GAZZINELLI, RICARDO TOSTES, LIEBERMAN, JUDY · 2016 to 2020
$3.2M
Monocyte-derived dendritic cells in malariaR01NS098747 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAZZINELLI, RICARDO TOSTES, LUSTER, ANDREW D · 2016 to 2020
$2.1M
Killing of P. vivax infected reticulocytes by cytotoxic T cellsR21AI131632 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAZZINELLI, RICARDO TOSTES, LIEBERMAN, JUDY · 2018 to 2019
$484k
NIAID NIH HHS R01 AI079293NIAID NIH HHS R01 AI116577NIAID NIH HHS R21 AI131632NIAID NIH HHS U19 AI089681NINDS NIH HHS R01 NS098747
6 · The paper itself

Abstract

Plasmodium vivax causes approximately 100 million clinical malaria cases yearly

Indexed as

Cytotoxicity, ImmunologicAntigens, Differentiation, T-LymphocyteCD8-Positive T-LymphocytesFemaleHLA AntigensHumansLymphocyte ActivationLymphocyte CountMalariaMalePlasmodium vivaxReticulocytesAntigens, Differentiation, T-LymphocyteGNLY protein, humanHLA Antigens

Identifiers

PMID30038217
PMCPMC6129205
OpenAlexW2883214941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.